Ya-li Lv
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 14, 2021
HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.
Journal: Cancer chemotherapy and pharmacology
Published: July 21, 2020
Curcumin inhibits the formation of atherosclerosis in ApoE-/- mice by suppressing cytomegalovirus activity in endothelial cells.
Journal: Life sciences
Published: February 05, 2020
Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 17, 2019
Akebia Saponin D inhibits the formation of atherosclerosis in ApoE-/- mice by attenuating oxidative stress-induced apoptosis in endothelial cells.
Journal: Atherosclerosis
Published: October 15, 2018
Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D.
Journal: European journal of pharmacology
Published: August 07, 2018
Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis.
Journal: Infection and drug resistance
Published: December 26, 2017
Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy.
Journal: Journal of pharmacological sciences
Published: September 26, 2017
VDR Gene variation and insulin resistance related diseases.
Journal: Lipids in health and disease
Published: March 13, 2017
Cytomegalovirus infection and atherosclerosis risk: A meta-analysis.
Journal: Journal of medical virology
Published: January 02, 2017
Last Updated: 09/26/2026